55154-4747 : Labetalol Hydrochloride 5 mg/ml Intravenous Injection, Solution


NDC: 55154-4747
Labeler: Cardinal Health
Product Type: Human Prescription Drug
Drug Name:  Labetalol Hydrochloride
Dosage Form: Intravenous Injection, Solution
Application #: ANDA075239
Rev. Date: 


NDC Package Codes:

  • 55154-4747-5: 5 SYRINGE IN 1 BAG (55154‑4747‑5) > 4 ML IN 1 SYRINGE

Active Ingredients:

  • Labetalol Hydrochloride

Dosage Strength:

  • 5 mg/mL

Pharmaceutical Classes:

  • Adrenergic beta-Antagonists [MoA]
  • beta-Adrenergic Blocker [EPC]

Related Products:

Based on records with the same trade name.
  • 55154-2339 Labetalol Hydrochloride 200 mg Oral Tablet, Film Coated by Cardinal Health
  • 55154-5876 Labetalol Hydrochloride 200 mg Oral Tablet by Cardinal Health
  • 55154-6641 Labetalol Hydrochloride 200 mg/1 Oral Tablet, Film Coated by Cardinal Health
  • 55154-6877 Labetalol Hydrochloride 100 mg Oral Tablet by Cardinal Health
  • 55154-7559 Labetalol Hydrochloride 100 mg Oral Tablet by Cardinal Health
  • 55154-7560 Labetalol Hydrochloride 200 mg Oral Tablet by Cardinal Health
  • 55154-8192 Labetalol Hydrochloride 100 mg Oral Tablet, Film Coated by Cardinal Health
  • 55154-4170 Labetalol Hydrochloride 100 mg Oral Tablet, Film Coated by Cardinal Health 107, LLC
  • 0143-9320 Labetalol Hydrochloride 5 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0143-9622 Labetalol Hydrochloride 5 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0143-9623 Labetalol Hydrochloride 5 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0172-4364 Labetalol Hydrochloride 100 mg Oral Tablet by Ivax Pharmaceuticals, Inc.
  • 0172-4365 Labetalol Hydrochloride 200 mg Oral Tablet by Ivax Pharmaceuticals, Inc.
  • 0172-4366 Labetalol Hydrochloride 300 mg Oral Tablet by Ivax Pharmaceuticals, Inc.
  • 0409-0125 Labetalol Hydrochloride 5 mg/ml Intravenous Injection, Solution by Hospira, Inc.
  • 0409-2267 Labetalol Hydrochloride 5 mg/ml Intravenous Injection, Solution by Hospira, Inc.
  • 0409-2339 Labetalol Hydrochloride 5 mg/ml Intravenous Injection, Solution by Hospira, Inc.
  • 0591-0605 Labetalol Hydrochloride 100 mg Oral Tablet by Watson Laboratories, Inc.
  • 0591-0606 Labetalol Hydrochloride 200 mg Oral Tablet by Watson Laboratories, Inc.
  • 0591-0607 Labetalol Hydrochloride 300 mg Oral Tablet by Watson Laboratories, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55154-4747 QR Code

< Prev: 55154-4746Next: 55154-4748 >

Related Discussions:

Labetalol hcl
I started with 100 mg twice per day of labetalol HCl. I immediately became so dry that I couldn't talk without a bot... 4 replies
labetalol side effects
Is Labetalol HCL compatible with Prednisone 10 mg + Chlorthalidone 10 mgm + Duloxetine 60 mgm + Amlodipine? My husband h... 2 replies
Labetalol Alternatives
My husband takes this pill and he is a diabetic with kidney disease. This medicine has his legs and feet feeling cold al... 1 reply
Labetalol in pregnancy
Our baby son has just been diagnosed with cht My partner is worried that use of labetalol in pregnancy may have caused o... 1 reply
Atenolol versus Labetalol
I want to know if it would be ok to take atenolol in place of the labetalol I've been taking, but ran out of? ## Hi ... 2 replies
What Would A Prescription Of Labetalol Have On The Bottle
what numbers would you find on a prescription bottle for labetalol identifying it as that drug. ## what numbers would yo... 2 replies
labetalol is superior than methyldopa
labetalol is alpha and beta blocker both as well as fast onset of action and renal impairement ## i m. gynecologist... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.